Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial.

NPJ Vaccines · 2025 · PMC12753722 · PMID 41315325

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

At Month 36, there was no evidence of a difference in HPV-specific GM memory B-cell frequencies between the 1 and 2-dose arms for Cervarix® for HPV16 or HPV18, or for Gardasil®9 for HPV18, and the difference was only of borderline significance for HPV16 for Gardasil®9 (95%CI = 0.32–0.96, Table 2 ).

also in 736 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.